GL1X · GenesisL1 explorer

MolNFT v1 · #115990 · protein

Crystal structure of bsha from B. subtilis complexed with N- acetylglucosaminyl-malate

5D01 · N-acetyl-alpha-D-glucosaminyl L-malate synthase: “Crystal structure of bsha from B. subtilis complexed with N- acetylglucosaminyl-malate”. X-ray diffraction, 1 ligand (GMT), 3 pockets (best druggability 0.74). MolNFT v1 #115990 on…

PDB
5D01
Type
protein
Length
717 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
N-acetyl-alpha-D-glucosaminyl L-malate synthase
EC
2.4.1.-
UniProt
P42982
Ligands
GMT
Pockets
3 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 48% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AN-acetyl-alpha-D-glucosaminyl L-malate synthase (EC 2.4.1.-)protein35748% helix, 17% strandP42982
BN-acetyl-alpha-D-glucosaminyl L-malate synthase (EC 2.4.1.-)protein36047% helix, 17% strandP42982

Ligands and binding sites

  • GMT · (2S)-2-{[2-acetamido-2-deoxy-alpha-D-glucopyranosyl]oxy}butanedioic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15060.740.8252GMT
23880.740.8438GMT
3560.290.7516empty

Interfaces

1 interface between chains.

  • A–B · 1909 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 5D01 · Crystal structure of BshA from B. subtilis complexed with N-acetylglucosaminyl-malate · the same entry in another collection · chain A against A, TM-score 1.00
  • P42982 · AlphaFold monomer V2.0 prediction for N-acetyl-alpha-D-glucosaminyl L-malate synthase… · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.